Bluebird Bio Stock Alpha and Beta Analysis

BLUE Stock  USD 0.35  0.05  16.67%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Bluebird bio. It also helps investors analyze the systematic and unsystematic risks associated with investing in Bluebird Bio over a specified time horizon. Remember, high Bluebird Bio's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Bluebird Bio's market risk premium analysis include:
Beta
1.92
Alpha
(1.10)
Risk
5.21
Sharpe Ratio
(0.15)
Expected Return
(0.78)
Please note that although Bluebird Bio alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Bluebird Bio did 1.10  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Bluebird bio stock's relative risk over its benchmark. Bluebird bio has a beta of 1.92  . As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Bluebird Bio will likely underperform. The current year's Enterprise Value is expected to grow to about 386.4 M, whereas Book Value Per Share is forecasted to decline to 1.68.

Enterprise Value

386.41 Million

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Bluebird Bio Backtesting, Bluebird Bio Valuation, Bluebird Bio Correlation, Bluebird Bio Hype Analysis, Bluebird Bio Volatility, Bluebird Bio History and analyze Bluebird Bio Performance.
For information on how to trade Bluebird Stock refer to our How to Trade Bluebird Stock guide.

Bluebird Bio Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Bluebird Bio market risk premium is the additional return an investor will receive from holding Bluebird Bio long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Bluebird Bio. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Bluebird Bio's performance over market.
α-1.1   β1.92

Bluebird Bio expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Bluebird Bio's Buy-and-hold return. Our buy-and-hold chart shows how Bluebird Bio performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Bluebird Bio Market Price Analysis

Market price analysis indicators help investors to evaluate how Bluebird Bio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Bluebird Bio shares will generate the highest return on investment. By understating and applying Bluebird Bio stock market price indicators, traders can identify Bluebird Bio position entry and exit signals to maximize returns.

Bluebird Bio Return and Market Media

The median price of Bluebird Bio for the period between Tue, Aug 27, 2024 and Mon, Nov 25, 2024 is 0.49 with a coefficient of variation of 17.72. The daily time series for the period is distributed with a sample standard deviation of 0.09, arithmetic mean of 0.49, and mean deviation of 0.06. The Stock received a lot of media exposure during the period.
 Price Growth (%)  
       Timeline  
1
Bluebird Q2 Earnings Snapshot
09/27/2024
2
bluebird bio Now Covered by Analysts at StockNews.com
10/09/2024
3
BLUE SUEDE HOSPITALITY GROUP NAMES SHADE GROUP AS AGENCY OF RECORD
11/04/2024
4
bluebird bio to Present Additional Long-Term Follow-up Data from Gene Therapy Programs in Sickle Cell Disease and Beta-Thalassemia at the 66th American Society ...
11/05/2024
5
bluebird bio Adjourns Meeting of Stockholders and Announces Third Quarter Results Call
11/06/2024
6
After Plunging -22.76 percent in 4 Weeks, Heres Why the Trend Might Reverse for Bluebird
11/08/2024
7
bluebird bio Q3 2024 Earnings Preview
11/13/2024
8
Earnings call Bluebird bio sees patient growth, aims for 2025 breakeven
11/14/2024
9
bluebird bio, Inc.s Revenues Are Not Doing Enough For Some Investors
11/15/2024
10
Bluebird Bios SWOT analysis gene therapy firm faces cash crunch amid launch
11/21/2024

About Bluebird Bio Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Bluebird or other stocks. Alpha measures the amount that position in Bluebird bio has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2021 2022 2023 2024 (projected)
Graham Number31.5913.818.778.33
Receivables Turnover0.320.332.272.15

Bluebird Bio Upcoming Company Events

As portrayed in its financial statements, the presentation of Bluebird Bio's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Bluebird Bio's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Bluebird Bio's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Bluebird Bio. Please utilize our Beneish M Score to check the likelihood of Bluebird Bio's management manipulating its earnings.
3rd of April 2024
Upcoming Quarterly Report
View
14th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
3rd of April 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with Bluebird Bio

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Bluebird bio is a strong investment it is important to analyze Bluebird Bio's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Bluebird Bio's future performance. For an informed investment choice regarding Bluebird Stock, refer to the following important reports:
Check out Bluebird Bio Backtesting, Bluebird Bio Valuation, Bluebird Bio Correlation, Bluebird Bio Hype Analysis, Bluebird Bio Volatility, Bluebird Bio History and analyze Bluebird Bio Performance.
For information on how to trade Bluebird Stock refer to our How to Trade Bluebird Stock guide.
You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Bluebird Bio technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Bluebird Bio technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Bluebird Bio trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...